The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded Greenwood Genetic Center Inc., doing business as Self Research Institute, a $50,000 firm fixed price purchase order for Clinical Genetic Testing for Undiagnosed Disease Program. Under the contract, Self Research Institute will provide clinical genetic testing services to support the National Institutes of Health's Clinical Genetic Testing for Undiagnosed Disease Program....
This federal contract award, valued at $89,127.00, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company and provider of genetic testing and diagnostic services. The contract is for medical laboratory testing services, primarily supporting research and clinical programs at the NIH. Genedx holds two significant Indefinite Delivery Vehicle (IDV) contracts with the NIH Clinical Center, one of which was set aside for small...
This firm fixed-price contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Genedx, LLC, a provider of genetic testing and diagnostic services. The $5,250 contract tasks Genedx with providing a range of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing, in support of NIH's clinical research missions. This contract is not set aside for any socioeconomic...
<p>The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $249,648.00 firm fixed price purchase order to Medical Neurogenetics, LLC, a for-profit organization, for clinical genetic testing services. The contract has a completion date of November 2, 2023 and does not have a set-aside designation. The place of performance is Bethesda, Maryland.</p>
This federal contract award, with an ID of 75N90018K00052, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The $82,281.25 firm fixed-price purchase order is for medical laboratory testing services, primarily to support research and clinical programs at the NIH. Genedx, a wholly-owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic services to the federal government. This...
This federal contract award, with ID HHSN269201700325PC, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The contract is for $95,385.00 and is for medical laboratory testing services, specifically supporting genetic testing and analysis. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Genedx competed in the open market for this award. Genedx, as a wholly owned subsidiary of...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Genedx, LLC, a wholly owned subsidiary of Opko Health, Inc. The contract provides laboratory testing services, including genetic testing and diagnostic services, to support research and clinical programs at the NIH. The contract has a ceiling value of $5,775 and a period of performance through May 22, 2023. The contract was awarded on...
This federal contract award is for medical laboratory testing services provided by Genedx, LLC to the National Institutes of Health (NIH) Clinical Center. The contract, valued at $100,000.00, is a firm fixed-price purchase order with an ultimate completion date of August 12, 2015. Genedx, a for-profit limited liability company, has been a provider of genetic testing services to the NIH, supporting various research and clinical programs, particularly at the NIH Clinical Center and the National...
The National Institutes of Health National Human Genome Research Institute awarded a $74,250 delivery order to The Johns Hopkins University under an unspecified government-wide acquisition contract. The firm fixed price order is for genotyping services using a global diversity array for genetic research being conducted by NIH's National Institute of Child Health and Human Development. Performance will occur at the prime contractor's Baltimore, Maryland location from September 2023 through...
Prevention Genetics LLC was awarded a one-year, firm fixed price purchase order valued at fifty thousand dollars by the National Institutes of Health Clinical Center of the Department of Health and Human Services. Under this contract, Prevention Genetics will provide unspecified services to NIH Clinical Center at its place of performance in Bethesda, Maryland, to support the agency's biomedical research mission. No major subcontractors or set aside designations were identified. The award...